Kiora Pharmaceuticals Inc
- Close
- Oct 29, 2026
- Market cap
- $7.79M
- 4.42M shares
- Filings
- 929
Q3 2026−100.0% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+129.3% FY25 yoy
- $7.79M
- —
- —
- 0.5×
- -129.34%
- —
FY2025 figures · derived
Price
Oct 29, 2026 · Official close
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $16,020,000 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2021 | 2021-12-31 | $0 | reported | |
| FY 2020 | 2020-12-31 | $12,059 | reported | |
| FY 2019 | 2019-12-31 | $2,686,000 | reported | |
| FY 2018 | 2018-12-31 | $1,652,520 | reported | |
| FY 2017 | 2017-12-31 | $407,518 | reported | |
| FY 2016 | 2016-12-31 | $669,259 | reported | |
| FY 2015 | 2015-12-31 | $0 | reported |
Pharmaceutical preparations
Kiora Pharmaceuticals Inc is the 429th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
VTGNVistagen Therapeutics, Inc.$1.3M161.1%5,491.3%$8.2MAEONAEON Biopharma, Inc.———$8.1M
KPRXKiora Pharmaceuticals Inc (this company)$0.0100.0%—$7.8M
ENSCEnsysce Biosciences, Inc.$5.1M2.8%200.8%$7.6MSNGXSoligenix, Inc.———$7.5MLTRNLantern Pharma Inc.———$7.4MACTUActuate Therapeutics, Inc.———$7.4MTOVXTheriva Biologics, Inc.———$7.4MCNSYCerenome, Inc.$5.2M10.5%429.4%$7.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Kiora Pharmaceuticals Inc · CIK 1372514 · Engraved from SEC EDGAR